1. Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Hospitalet de Llobregat, 08907 Barcelona, Spain.
2. Biomedical Research Institute of Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
3. Centres Científics i Tecnològics, Universitat de Barcelona, Campus Bellvitge, Barcelona, Spain.
4. Biomedical Research Institute of Bellvitge (IDIBELL), Oncobell Program, CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.